Cosmos Health (NASDAQ:COSM – Get Free Report) is expected to post its results on Friday, November 13th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $17.34 million for the quarter.
Cosmos Health (NASDAQ:COSM – Get Free Report) last announced its quarterly earnings results on Tuesday, August 18th. The company reported ($0.10) EPS for the quarter, meeting the consensus estimate of ($0.10). The company had revenue of $19.32 million for the quarter, compared to analyst estimates of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative return on equity of 56.88%. On average, analysts expect Cosmos Health to post ($0.15) EPS for the current fiscal year and $0.07 EPS for the next fiscal year.
Cosmos Health Trading Up 19.4%
Shares of NASDAQ:COSM opened at $0.24 on Thursday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.92 and a current ratio of 1.05. Cosmos Health has a twelve month low of $0.16 and a twelve month high of $0.77. The firm has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.30.
Analyst Upgrades and Downgrades
COSM has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 28th. Noble Financial assumed coverage on shares of Cosmos Health in a research note on Monday, October 26th. They set an “outperform” rating on the stock. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Read Our Latest Report on COSM
Cosmos Health Company Profile
Cosmos Health Inc. is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels. The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.
Read More
- Five stocks we like better than Cosmos Health
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
